Early response to desipramine among women with bulimia nervosa

B. Timothy Walsh, Robyn Sysko, Michael K. Parides

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective: Numerous trials have demonstrated the efficacy of antidepressant medications for the treatment of bulimia nervosa (BN). The current study examined whether early response to medication predicted response to medication at the end of a controlled trial. Method: Data from two previously published studies of desipramine (DMI) were used. Seventy-seven patients with BN were included in the analysis. Receiver operating characteristic (ROC) curves were constructed to examine the relation between the percentage reduction in symptoms at each week and failure to respond to antidepressant medication at the end of the trial. Results: Eventual nonresponders to DMI could be reliably identified in the first 2 weeks of treatment. Discussion: The current study provides preliminary evidence that patients with BN who will not respond to antidepressant medication can be identified in the first 2 weeks of treatment.

Original languageEnglish (US)
Pages (from-to)72-75
Number of pages4
JournalInternational Journal of Eating Disorders
Volume39
Issue number1
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Bulimia Nervosa
Desipramine
Antidepressive Agents
ROC Curve
Therapeutics

Keywords

  • Antidepressant medication
  • Bulimia nervosa
  • Desipramine
  • Receiver operating characteristic curves

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Early response to desipramine among women with bulimia nervosa. / Walsh, B. Timothy; Sysko, Robyn; Parides, Michael K.

In: International Journal of Eating Disorders, Vol. 39, No. 1, 01.01.2006, p. 72-75.

Research output: Contribution to journalArticle

@article{be463e8ae46b4dbfa2797c610c335606,
title = "Early response to desipramine among women with bulimia nervosa",
abstract = "Objective: Numerous trials have demonstrated the efficacy of antidepressant medications for the treatment of bulimia nervosa (BN). The current study examined whether early response to medication predicted response to medication at the end of a controlled trial. Method: Data from two previously published studies of desipramine (DMI) were used. Seventy-seven patients with BN were included in the analysis. Receiver operating characteristic (ROC) curves were constructed to examine the relation between the percentage reduction in symptoms at each week and failure to respond to antidepressant medication at the end of the trial. Results: Eventual nonresponders to DMI could be reliably identified in the first 2 weeks of treatment. Discussion: The current study provides preliminary evidence that patients with BN who will not respond to antidepressant medication can be identified in the first 2 weeks of treatment.",
keywords = "Antidepressant medication, Bulimia nervosa, Desipramine, Receiver operating characteristic curves",
author = "Walsh, {B. Timothy} and Robyn Sysko and Parides, {Michael K.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1002/eat.20209",
language = "English (US)",
volume = "39",
pages = "72--75",
journal = "International Journal of Eating Disorders",
issn = "0276-3478",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Early response to desipramine among women with bulimia nervosa

AU - Walsh, B. Timothy

AU - Sysko, Robyn

AU - Parides, Michael K.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Objective: Numerous trials have demonstrated the efficacy of antidepressant medications for the treatment of bulimia nervosa (BN). The current study examined whether early response to medication predicted response to medication at the end of a controlled trial. Method: Data from two previously published studies of desipramine (DMI) were used. Seventy-seven patients with BN were included in the analysis. Receiver operating characteristic (ROC) curves were constructed to examine the relation between the percentage reduction in symptoms at each week and failure to respond to antidepressant medication at the end of the trial. Results: Eventual nonresponders to DMI could be reliably identified in the first 2 weeks of treatment. Discussion: The current study provides preliminary evidence that patients with BN who will not respond to antidepressant medication can be identified in the first 2 weeks of treatment.

AB - Objective: Numerous trials have demonstrated the efficacy of antidepressant medications for the treatment of bulimia nervosa (BN). The current study examined whether early response to medication predicted response to medication at the end of a controlled trial. Method: Data from two previously published studies of desipramine (DMI) were used. Seventy-seven patients with BN were included in the analysis. Receiver operating characteristic (ROC) curves were constructed to examine the relation between the percentage reduction in symptoms at each week and failure to respond to antidepressant medication at the end of the trial. Results: Eventual nonresponders to DMI could be reliably identified in the first 2 weeks of treatment. Discussion: The current study provides preliminary evidence that patients with BN who will not respond to antidepressant medication can be identified in the first 2 weeks of treatment.

KW - Antidepressant medication

KW - Bulimia nervosa

KW - Desipramine

KW - Receiver operating characteristic curves

UR - http://www.scopus.com/inward/record.url?scp=31144453221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31144453221&partnerID=8YFLogxK

U2 - 10.1002/eat.20209

DO - 10.1002/eat.20209

M3 - Article

C2 - 16254873

AN - SCOPUS:31144453221

VL - 39

SP - 72

EP - 75

JO - International Journal of Eating Disorders

JF - International Journal of Eating Disorders

SN - 0276-3478

IS - 1

ER -